nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluticasone Propionate—CYP3A7-CYP3A51P—Simvastatin—atherosclerosis	0.0822	0.118	CbGbCtD
Fluticasone Propionate—CYP3A7—Simvastatin—atherosclerosis	0.0822	0.118	CbGbCtD
Fluticasone Propionate—CYP3A7-CYP3A51P—Lovastatin—atherosclerosis	0.0804	0.115	CbGbCtD
Fluticasone Propionate—CYP3A7—Lovastatin—atherosclerosis	0.0804	0.115	CbGbCtD
Fluticasone Propionate—CYP3A5—Rosuvastatin—atherosclerosis	0.0663	0.0952	CbGbCtD
Fluticasone Propionate—CYP3A5—Simvastatin—atherosclerosis	0.0616	0.0885	CbGbCtD
Fluticasone Propionate—CYP3A5—Pravastatin—atherosclerosis	0.0603	0.0866	CbGbCtD
Fluticasone Propionate—CYP3A5—Lovastatin—atherosclerosis	0.0603	0.0866	CbGbCtD
Fluticasone Propionate—CYP3A4—Rosuvastatin—atherosclerosis	0.0259	0.0371	CbGbCtD
Fluticasone Propionate—CYP3A4—Ezetimibe—atherosclerosis	0.0259	0.0371	CbGbCtD
Fluticasone Propionate—CYP3A4—Simvastatin—atherosclerosis	0.024	0.0345	CbGbCtD
Fluticasone Propionate—CYP3A4—Pravastatin—atherosclerosis	0.0235	0.0338	CbGbCtD
Fluticasone Propionate—CYP3A4—Lovastatin—atherosclerosis	0.0235	0.0338	CbGbCtD
Fluticasone Propionate—Ache—Lovastatin—atherosclerosis	0.00357	0.0221	CcSEcCtD
Fluticasone Propionate—Ache—Simvastatin—atherosclerosis	0.00334	0.0207	CcSEcCtD
Fluticasone Propionate—Ache—Pravastatin—atherosclerosis	0.00302	0.0187	CcSEcCtD
Fluticasone Propionate—Eye irritation—Lovastatin—atherosclerosis	0.00193	0.012	CcSEcCtD
Fluticasone Propionate—Glaucoma—Niacin—atherosclerosis	0.00188	0.0117	CcSEcCtD
Fluticasone Propionate—Endocrine disorder—Simvastatin—atherosclerosis	0.00186	0.0115	CcSEcCtD
Fluticasone Propionate—Viral infection—Ezetimibe—atherosclerosis	0.00179	0.0111	CcSEcCtD
Fluticasone Propionate—Cataract—Lovastatin—atherosclerosis	0.00173	0.0107	CcSEcCtD
Fluticasone Propionate—Sleep disorder—Rosuvastatin—atherosclerosis	0.00163	0.0101	CcSEcCtD
Fluticasone Propionate—Diabetes mellitus—Rosuvastatin—atherosclerosis	0.00162	0.0101	CcSEcCtD
Fluticasone Propionate—Cataract—Simvastatin—atherosclerosis	0.00162	0.01	CcSEcCtD
Fluticasone Propionate—Viral infection—Pravastatin—atherosclerosis	0.00154	0.00957	CcSEcCtD
Fluticasone Propionate—Cataract—Pravastatin—atherosclerosis	0.00146	0.00908	CcSEcCtD
Fluticasone Propionate—Betamethasone—PLA2G1B—atherosclerosis	0.00143	0.454	CrCbGaD
Fluticasone Propionate—Dermatitis contact—Niacin—atherosclerosis	0.0014	0.00868	CcSEcCtD
Fluticasone Propionate—Sleep disorder—Simvastatin—atherosclerosis	0.00129	0.00802	CcSEcCtD
Fluticasone Propionate—Diabetes mellitus—Simvastatin—atherosclerosis	0.00129	0.00798	CcSEcCtD
Fluticasone Propionate—Eczema—Simvastatin—atherosclerosis	0.00124	0.00773	CcSEcCtD
Fluticasone Propionate—Diabetes mellitus—Niacin—atherosclerosis	0.00118	0.00733	CcSEcCtD
Fluticasone Propionate—Atrial fibrillation—Simvastatin—atherosclerosis	0.00118	0.00733	CcSEcCtD
Fluticasone Propionate—Bronchitis—Rosuvastatin—atherosclerosis	0.00117	0.00728	CcSEcCtD
Fluticasone Propionate—Sleep disorder—Pravastatin—atherosclerosis	0.00117	0.00725	CcSEcCtD
Fluticasone Propionate—PGR—artery—atherosclerosis	0.00115	0.131	CbGeAlD
Fluticasone Propionate—Eczema—Niacin—atherosclerosis	0.00114	0.00709	CcSEcCtD
Fluticasone Propionate—Atrial fibrillation—Niacin—atherosclerosis	0.00108	0.00673	CcSEcCtD
Fluticasone Propionate—Cramp muscle—Lovastatin—atherosclerosis	0.00108	0.00668	CcSEcCtD
Fluticasone Propionate—Dermatitis bullous—Niacin—atherosclerosis	0.00107	0.00667	CcSEcCtD
Fluticasone Propionate—Cramp muscle—Ezetimibe—atherosclerosis	0.00106	0.00656	CcSEcCtD
Fluticasone Propionate—Nasopharyngitis—Ezetimibe—atherosclerosis	0.00105	0.00651	CcSEcCtD
Fluticasone Propionate—Sinusitis—Rosuvastatin—atherosclerosis	0.00102	0.00633	CcSEcCtD
Fluticasone Propionate—Cramp muscle—Simvastatin—atherosclerosis	0.00101	0.00625	CcSEcCtD
Fluticasone Propionate—Face oedema—Niacin—atherosclerosis	0.000992	0.00615	CcSEcCtD
Fluticasone Propionate—Abdominal discomfort—Lovastatin—atherosclerosis	0.000991	0.00615	CcSEcCtD
Fluticasone Propionate—Pharyngitis—Rosuvastatin—atherosclerosis	0.000969	0.00601	CcSEcCtD
Fluticasone Propionate—Upper respiratory tract infection—Ezetimibe—atherosclerosis	0.000942	0.00585	CcSEcCtD
Fluticasone Propionate—Bronchitis—Simvastatin—atherosclerosis	0.00093	0.00577	CcSEcCtD
Fluticasone Propionate—Abdominal discomfort—Simvastatin—atherosclerosis	0.000927	0.00575	CcSEcCtD
Fluticasone Propionate—Cramp muscle—Pravastatin—atherosclerosis	0.000911	0.00565	CcSEcCtD
Fluticasone Propionate—Nasopharyngitis—Pravastatin—atherosclerosis	0.000904	0.00561	CcSEcCtD
Fluticasone Propionate—Infestation NOS—Ezetimibe—atherosclerosis	0.000904	0.00561	CcSEcCtD
Fluticasone Propionate—Infestation—Ezetimibe—atherosclerosis	0.000904	0.00561	CcSEcCtD
Fluticasone Propionate—Upper respiratory tract infection—Simvastatin—atherosclerosis	0.000899	0.00558	CcSEcCtD
Fluticasone Propionate—Abdominal distension—Niacin—atherosclerosis	0.000894	0.00555	CcSEcCtD
Fluticasone Propionate—PGR—blood vessel—atherosclerosis	0.000892	0.102	CbGeAlD
Fluticasone Propionate—Abdominal distension—Pravastatin—atherosclerosis	0.00088	0.00546	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Rosuvastatin—atherosclerosis	0.000872	0.00541	CcSEcCtD
Fluticasone Propionate—Sinusitis—Lovastatin—atherosclerosis	0.000865	0.00537	CcSEcCtD
Fluticasone Propionate—Mental disorder—Rosuvastatin—atherosclerosis	0.000855	0.00531	CcSEcCtD
Fluticasone Propionate—Bronchitis—Niacin—atherosclerosis	0.000854	0.0053	CcSEcCtD
Fluticasone Propionate—Sinusitis—Ezetimibe—atherosclerosis	0.000848	0.00526	CcSEcCtD
Fluticasone Propionate—Dexamethasone—PLA2G1B—atherosclerosis	0.000829	0.264	CrCbGaD
Fluticasone Propionate—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.000812	0.00504	CcSEcCtD
Fluticasone Propionate—Sinusitis—Simvastatin—atherosclerosis	0.000809	0.00502	CcSEcCtD
Fluticasone Propionate—Pharyngitis—Ezetimibe—atherosclerosis	0.000805	0.005	CcSEcCtD
Fluticasone Propionate—Connective tissue disorder—Ezetimibe—atherosclerosis	0.000798	0.00495	CcSEcCtD
Fluticasone Propionate—Angioedema—Rosuvastatin—atherosclerosis	0.000777	0.00482	CcSEcCtD
Fluticasone Propionate—Cough—Rosuvastatin—atherosclerosis	0.000742	0.0046	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Ezetimibe—atherosclerosis	0.000733	0.00455	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Ezetimibe—atherosclerosis	0.000731	0.00454	CcSEcCtD
Fluticasone Propionate—Sinusitis—Pravastatin—atherosclerosis	0.000731	0.00454	CcSEcCtD
Fluticasone Propionate—Arthralgia—Rosuvastatin—atherosclerosis	0.000724	0.00449	CcSEcCtD
Fluticasone Propionate—Mental disorder—Ezetimibe—atherosclerosis	0.000711	0.00441	CcSEcCtD
Fluticasone Propionate—Hypoaesthesia—Niacin—atherosclerosis	0.000707	0.00439	CcSEcCtD
Fluticasone Propionate—Erythema—Ezetimibe—atherosclerosis	0.000706	0.00438	CcSEcCtD
Fluticasone Propionate—Malnutrition—Ezetimibe—atherosclerosis	0.000706	0.00438	CcSEcCtD
Fluticasone Propionate—Hypoaesthesia—Pravastatin—atherosclerosis	0.000696	0.00432	CcSEcCtD
Fluticasone Propionate—Pharyngitis—Pravastatin—atherosclerosis	0.000694	0.00431	CcSEcCtD
Fluticasone Propionate—Muscle spasms—Lovastatin—atherosclerosis	0.000693	0.0043	CcSEcCtD
Fluticasone Propionate—Infection—Rosuvastatin—atherosclerosis	0.000689	0.00428	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00068	0.00422	CcSEcCtD
Fluticasone Propionate—Muscle spasms—Ezetimibe—atherosclerosis	0.000679	0.00422	CcSEcCtD
Fluticasone Propionate—Vision blurred—Lovastatin—atherosclerosis	0.000679	0.00421	CcSEcCtD
Fluticasone Propionate—Mental disorder—Simvastatin—atherosclerosis	0.000678	0.00421	CcSEcCtD
Fluticasone Propionate—Tremor—Lovastatin—atherosclerosis	0.000675	0.00419	CcSEcCtD
Fluticasone Propionate—Erythema—Simvastatin—atherosclerosis	0.000674	0.00418	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Lovastatin—atherosclerosis	0.000668	0.00415	CcSEcCtD
Fluticasone Propionate—Eye disorder—Niacin—atherosclerosis	0.000664	0.00412	CcSEcCtD
Fluticasone Propionate—Angioedema—Lovastatin—atherosclerosis	0.000658	0.00408	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000655	0.00407	CcSEcCtD
Fluticasone Propionate—Malaise—Lovastatin—atherosclerosis	0.00065	0.00403	CcSEcCtD
Fluticasone Propionate—Cardiac disorder—Pravastatin—atherosclerosis	0.000649	0.00403	CcSEcCtD
Fluticasone Propionate—Muscle spasms—Simvastatin—atherosclerosis	0.000648	0.00402	CcSEcCtD
Fluticasone Propionate—Angioedema—Ezetimibe—atherosclerosis	0.000646	0.00401	CcSEcCtD
Fluticasone Propionate—Malaise—Ezetimibe—atherosclerosis	0.000637	0.00395	CcSEcCtD
Fluticasone Propionate—Vision blurred—Simvastatin—atherosclerosis	0.000635	0.00394	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Niacin—atherosclerosis	0.000635	0.00394	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000632	0.00392	CcSEcCtD
Fluticasone Propionate—Tremor—Simvastatin—atherosclerosis	0.000631	0.00392	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Simvastatin—atherosclerosis	0.000625	0.00388	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Pravastatin—atherosclerosis	0.000625	0.00388	CcSEcCtD
Fluticasone Propionate—Palpitations—Ezetimibe—atherosclerosis	0.000624	0.00387	CcSEcCtD
Fluticasone Propionate—Malnutrition—Niacin—atherosclerosis	0.000619	0.00384	CcSEcCtD
Fluticasone Propionate—Erythema—Niacin—atherosclerosis	0.000619	0.00384	CcSEcCtD
Fluticasone Propionate—Cough—Ezetimibe—atherosclerosis	0.000616	0.00383	CcSEcCtD
Fluticasone Propionate—Angioedema—Simvastatin—atherosclerosis	0.000616	0.00382	CcSEcCtD
Fluticasone Propionate—Arthralgia—Lovastatin—atherosclerosis	0.000613	0.00381	CcSEcCtD
Fluticasone Propionate—Chest pain—Lovastatin—atherosclerosis	0.000613	0.00381	CcSEcCtD
Fluticasone Propionate—Anxiety—Lovastatin—atherosclerosis	0.000611	0.00379	CcSEcCtD
Fluticasone Propionate—Hypertension—Ezetimibe—atherosclerosis	0.00061	0.00379	CcSEcCtD
Fluticasone Propionate—Malaise—Simvastatin—atherosclerosis	0.000608	0.00377	CcSEcCtD
Fluticasone Propionate—Discomfort—Lovastatin—atherosclerosis	0.000606	0.00376	CcSEcCtD
Fluticasone Propionate—PLA2G4A—connective tissue—atherosclerosis	0.000605	0.069	CbGeAlD
Fluticasone Propionate—Arthralgia—Ezetimibe—atherosclerosis	0.000601	0.00373	CcSEcCtD
Fluticasone Propionate—Chest pain—Ezetimibe—atherosclerosis	0.000601	0.00373	CcSEcCtD
Fluticasone Propionate—Dry mouth—Lovastatin—atherosclerosis	0.0006	0.00372	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000597	0.00371	CcSEcCtD
Fluticasone Propionate—Muscle spasms—Niacin—atherosclerosis	0.000595	0.00369	CcSEcCtD
Fluticasone Propionate—Discomfort—Ezetimibe—atherosclerosis	0.000594	0.00369	CcSEcCtD
Fluticasone Propionate—Pain—Rosuvastatin—atherosclerosis	0.000593	0.00368	CcSEcCtD
Fluticasone Propionate—Dry mouth—Ezetimibe—atherosclerosis	0.000588	0.00365	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Lovastatin—atherosclerosis	0.000588	0.00365	CcSEcCtD
Fluticasone Propionate—Muscle spasms—Pravastatin—atherosclerosis	0.000586	0.00363	CcSEcCtD
Fluticasone Propionate—Infection—Lovastatin—atherosclerosis	0.000584	0.00362	CcSEcCtD
Fluticasone Propionate—Vision blurred—Niacin—atherosclerosis	0.000583	0.00362	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000577	0.00358	CcSEcCtD
Fluticasone Propionate—Vision blurred—Pravastatin—atherosclerosis	0.000574	0.00356	CcSEcCtD
Fluticasone Propionate—Arthralgia—Simvastatin—atherosclerosis	0.000574	0.00356	CcSEcCtD
Fluticasone Propionate—Chest pain—Simvastatin—atherosclerosis	0.000574	0.00356	CcSEcCtD
Fluticasone Propionate—Infection—Ezetimibe—atherosclerosis	0.000573	0.00355	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000572	0.00355	CcSEcCtD
Fluticasone Propionate—Anxiety—Simvastatin—atherosclerosis	0.000572	0.00355	CcSEcCtD
Fluticasone Propionate—Tremor—Pravastatin—atherosclerosis	0.000571	0.00354	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000567	0.00352	CcSEcCtD
Fluticasone Propionate—Discomfort—Simvastatin—atherosclerosis	0.000567	0.00352	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Ezetimibe—atherosclerosis	0.000565	0.00351	CcSEcCtD
Fluticasone Propionate—Angioedema—Niacin—atherosclerosis	0.000565	0.00351	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Pravastatin—atherosclerosis	0.000565	0.00351	CcSEcCtD
Fluticasone Propionate—Skin disorder—Ezetimibe—atherosclerosis	0.00056	0.00348	CcSEcCtD
Fluticasone Propionate—Angioedema—Pravastatin—atherosclerosis	0.000557	0.00345	CcSEcCtD
Fluticasone Propionate—Urticaria—Rosuvastatin—atherosclerosis	0.000551	0.00342	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Simvastatin—atherosclerosis	0.00055	0.00341	CcSEcCtD
Fluticasone Propionate—Oedema—Simvastatin—atherosclerosis	0.00055	0.00341	CcSEcCtD
Fluticasone Propionate—Malaise—Pravastatin—atherosclerosis	0.000549	0.00341	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Rosuvastatin—atherosclerosis	0.000548	0.0034	CcSEcCtD
Fluticasone Propionate—Palpitations—Niacin—atherosclerosis	0.000547	0.00339	CcSEcCtD
Fluticasone Propionate—Infection—Simvastatin—atherosclerosis	0.000546	0.00339	CcSEcCtD
Fluticasone Propionate—Cough—Niacin—atherosclerosis	0.00054	0.00335	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000536	0.00332	CcSEcCtD
Fluticasone Propionate—Cough—Pravastatin—atherosclerosis	0.000532	0.0033	CcSEcCtD
Fluticasone Propionate—Arthralgia—Niacin—atherosclerosis	0.000527	0.00327	CcSEcCtD
Fluticasone Propionate—PLA2G4A—cardiovascular system—atherosclerosis	0.000526	0.06	CbGeAlD
Fluticasone Propionate—Hypertension—Pravastatin—atherosclerosis	0.000526	0.00326	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000525	0.00326	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Lovastatin—atherosclerosis	0.000524	0.00325	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000523	0.00325	CcSEcCtD
Fluticasone Propionate—Arthralgia—Pravastatin—atherosclerosis	0.000519	0.00322	CcSEcCtD
Fluticasone Propionate—Chest pain—Pravastatin—atherosclerosis	0.000519	0.00322	CcSEcCtD
Fluticasone Propionate—Anxiety—Pravastatin—atherosclerosis	0.000517	0.00321	CcSEcCtD
Fluticasone Propionate—Dry mouth—Niacin—atherosclerosis	0.000515	0.0032	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Ezetimibe—atherosclerosis	0.000514	0.00319	CcSEcCtD
Fluticasone Propionate—Discomfort—Pravastatin—atherosclerosis	0.000512	0.00318	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000511	0.00317	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Niacin—atherosclerosis	0.000505	0.00313	CcSEcCtD
Fluticasone Propionate—Oedema—Niacin—atherosclerosis	0.000505	0.00313	CcSEcCtD
Fluticasone Propionate—Pain—Lovastatin—atherosclerosis	0.000503	0.00312	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000501	0.00311	CcSEcCtD
Fluticasone Propionate—Oedema—Pravastatin—atherosclerosis	0.000497	0.00309	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Pravastatin—atherosclerosis	0.000497	0.00309	CcSEcCtD
Fluticasone Propionate—Infection—Pravastatin—atherosclerosis	0.000494	0.00307	CcSEcCtD
Fluticasone Propionate—Pain—Ezetimibe—atherosclerosis	0.000493	0.00306	CcSEcCtD
Fluticasone Propionate—Tachycardia—Niacin—atherosclerosis	0.000493	0.00306	CcSEcCtD
Fluticasone Propionate—NR3C2—connective tissue—atherosclerosis	0.000492	0.0561	CbGeAlD
Fluticasone Propionate—Pruritus—Rosuvastatin—atherosclerosis	0.000491	0.00305	CcSEcCtD
Fluticasone Propionate—Skin disorder—Niacin—atherosclerosis	0.00049	0.00304	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Simvastatin—atherosclerosis	0.00049	0.00304	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Lovastatin—atherosclerosis	0.000484	0.00301	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000481	0.00298	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Ezetimibe—atherosclerosis	0.000475	0.00295	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Rosuvastatin—atherosclerosis	0.000475	0.00295	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000471	0.00293	CcSEcCtD
Fluticasone Propionate—Pain—Simvastatin—atherosclerosis	0.00047	0.00292	CcSEcCtD
Fluticasone Propionate—Urticaria—Lovastatin—atherosclerosis	0.000467	0.0029	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Lovastatin—atherosclerosis	0.000465	0.00288	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Lovastatin—atherosclerosis	0.000465	0.00288	CcSEcCtD
Fluticasone Propionate—PLA2G4A—adipose tissue—atherosclerosis	0.000464	0.0529	CbGeAlD
Fluticasone Propionate—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00046	0.00285	CcSEcCtD
Fluticasone Propionate—Dizziness—Rosuvastatin—atherosclerosis	0.000459	0.00285	CcSEcCtD
Fluticasone Propionate—Urticaria—Ezetimibe—atherosclerosis	0.000458	0.00284	CcSEcCtD
Fluticasone Propionate—PGR—connective tissue—atherosclerosis	0.000457	0.0522	CbGeAlD
Fluticasone Propionate—Body temperature increased—Ezetimibe—atherosclerosis	0.000456	0.00283	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Ezetimibe—atherosclerosis	0.000456	0.00283	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Simvastatin—atherosclerosis	0.000453	0.00281	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000453	0.00281	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Niacin—atherosclerosis	0.00045	0.00279	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00045	0.00279	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Pravastatin—atherosclerosis	0.000443	0.00275	CcSEcCtD
Fluticasone Propionate—Rash—Rosuvastatin—atherosclerosis	0.000437	0.00271	CcSEcCtD
Fluticasone Propionate—Dermatitis—Rosuvastatin—atherosclerosis	0.000437	0.00271	CcSEcCtD
Fluticasone Propionate—Urticaria—Simvastatin—atherosclerosis	0.000437	0.00271	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Simvastatin—atherosclerosis	0.000435	0.0027	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Simvastatin—atherosclerosis	0.000435	0.0027	CcSEcCtD
Fluticasone Propionate—Headache—Rosuvastatin—atherosclerosis	0.000435	0.0027	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Lovastatin—atherosclerosis	0.000433	0.00269	CcSEcCtD
Fluticasone Propionate—Pain—Niacin—atherosclerosis	0.000432	0.00268	CcSEcCtD
Fluticasone Propionate—NR3C2—cardiovascular system—atherosclerosis	0.000428	0.0488	CbGeAlD
Fluticasone Propionate—Pain—Pravastatin—atherosclerosis	0.000425	0.00264	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Ezetimibe—atherosclerosis	0.000425	0.00264	CcSEcCtD
Fluticasone Propionate—Pruritus—Lovastatin—atherosclerosis	0.000416	0.00258	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Niacin—atherosclerosis	0.000413	0.00256	CcSEcCtD
Fluticasone Propionate—Nausea—Rosuvastatin—atherosclerosis	0.000412	0.00256	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Pravastatin—atherosclerosis	0.00041	0.00254	CcSEcCtD
Fluticasone Propionate—Pruritus—Ezetimibe—atherosclerosis	0.000408	0.00253	CcSEcCtD
Fluticasone Propionate—CYP3A7—liver—atherosclerosis	0.000407	0.0464	CbGeAlD
Fluticasone Propionate—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000406	0.00252	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Simvastatin—atherosclerosis	0.000405	0.00251	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Lovastatin—atherosclerosis	0.000402	0.0025	CcSEcCtD
Fluticasone Propionate—Urticaria—Niacin—atherosclerosis	0.000401	0.00249	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Niacin—atherosclerosis	0.000399	0.00248	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Niacin—atherosclerosis	0.000399	0.00248	CcSEcCtD
Fluticasone Propionate—PGR—cardiovascular system—atherosclerosis	0.000398	0.0454	CbGeAlD
Fluticasone Propionate—Urticaria—Pravastatin—atherosclerosis	0.000395	0.00245	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Ezetimibe—atherosclerosis	0.000395	0.00245	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Pravastatin—atherosclerosis	0.000393	0.00244	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Pravastatin—atherosclerosis	0.000393	0.00244	CcSEcCtD
Fluticasone Propionate—Pruritus—Simvastatin—atherosclerosis	0.000389	0.00241	CcSEcCtD
Fluticasone Propionate—Dizziness—Lovastatin—atherosclerosis	0.000389	0.00241	CcSEcCtD
Fluticasone Propionate—Dizziness—Ezetimibe—atherosclerosis	0.000381	0.00237	CcSEcCtD
Fluticasone Propionate—NR3C2—adipose tissue—atherosclerosis	0.000377	0.0431	CbGeAlD
Fluticasone Propionate—Diarrhoea—Simvastatin—atherosclerosis	0.000376	0.00233	CcSEcCtD
Fluticasone Propionate—Vomiting—Lovastatin—atherosclerosis	0.000374	0.00232	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Niacin—atherosclerosis	0.000372	0.00231	CcSEcCtD
Fluticasone Propionate—Rash—Lovastatin—atherosclerosis	0.000371	0.0023	CcSEcCtD
Fluticasone Propionate—Dexamethasone—NOS2—atherosclerosis	0.00037	0.118	CrCbGaD
Fluticasone Propionate—Dermatitis—Lovastatin—atherosclerosis	0.00037	0.0023	CcSEcCtD
Fluticasone Propionate—Headache—Lovastatin—atherosclerosis	0.000368	0.00229	CcSEcCtD
Fluticasone Propionate—Vomiting—Ezetimibe—atherosclerosis	0.000367	0.00228	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Pravastatin—atherosclerosis	0.000366	0.00227	CcSEcCtD
Fluticasone Propionate—Dizziness—Simvastatin—atherosclerosis	0.000364	0.00226	CcSEcCtD
Fluticasone Propionate—Rash—Ezetimibe—atherosclerosis	0.000364	0.00226	CcSEcCtD
Fluticasone Propionate—Dermatitis—Ezetimibe—atherosclerosis	0.000363	0.00225	CcSEcCtD
Fluticasone Propionate—Headache—Ezetimibe—atherosclerosis	0.000361	0.00224	CcSEcCtD
Fluticasone Propionate—Pruritus—Niacin—atherosclerosis	0.000357	0.00222	CcSEcCtD
Fluticasone Propionate—Pruritus—Pravastatin—atherosclerosis	0.000352	0.00218	CcSEcCtD
Fluticasone Propionate—PGR—adipose tissue—atherosclerosis	0.000351	0.04	CbGeAlD
Fluticasone Propionate—Vomiting—Simvastatin—atherosclerosis	0.00035	0.00217	CcSEcCtD
Fluticasone Propionate—Nausea—Lovastatin—atherosclerosis	0.000349	0.00217	CcSEcCtD
Fluticasone Propionate—Rash—Simvastatin—atherosclerosis	0.000347	0.00215	CcSEcCtD
Fluticasone Propionate—Dermatitis—Simvastatin—atherosclerosis	0.000346	0.00215	CcSEcCtD
Fluticasone Propionate—CYP3A7-CYP3A51P—liver—atherosclerosis	0.000346	0.0394	CbGeAlD
Fluticasone Propionate—Diarrhoea—Niacin—atherosclerosis	0.000345	0.00214	CcSEcCtD
Fluticasone Propionate—Headache—Simvastatin—atherosclerosis	0.000344	0.00214	CcSEcCtD
Fluticasone Propionate—Nausea—Ezetimibe—atherosclerosis	0.000342	0.00213	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Pravastatin—atherosclerosis	0.00034	0.00211	CcSEcCtD
Fluticasone Propionate—Dizziness—Niacin—atherosclerosis	0.000334	0.00207	CcSEcCtD
Fluticasone Propionate—Dizziness—Pravastatin—atherosclerosis	0.000329	0.00204	CcSEcCtD
Fluticasone Propionate—Nausea—Simvastatin—atherosclerosis	0.000327	0.00203	CcSEcCtD
Fluticasone Propionate—SERPINA6—liver—atherosclerosis	0.000324	0.037	CbGeAlD
Fluticasone Propionate—Vomiting—Niacin—atherosclerosis	0.000321	0.00199	CcSEcCtD
Fluticasone Propionate—Rash—Niacin—atherosclerosis	0.000318	0.00198	CcSEcCtD
Fluticasone Propionate—Dermatitis—Niacin—atherosclerosis	0.000318	0.00197	CcSEcCtD
Fluticasone Propionate—Headache—Niacin—atherosclerosis	0.000316	0.00196	CcSEcCtD
Fluticasone Propionate—Vomiting—Pravastatin—atherosclerosis	0.000316	0.00196	CcSEcCtD
Fluticasone Propionate—Rash—Pravastatin—atherosclerosis	0.000313	0.00195	CcSEcCtD
Fluticasone Propionate—Dermatitis—Pravastatin—atherosclerosis	0.000313	0.00194	CcSEcCtD
Fluticasone Propionate—Headache—Pravastatin—atherosclerosis	0.000311	0.00193	CcSEcCtD
Fluticasone Propionate—Nausea—Niacin—atherosclerosis	0.0003	0.00186	CcSEcCtD
Fluticasone Propionate—Nausea—Pravastatin—atherosclerosis	0.000295	0.00183	CcSEcCtD
Fluticasone Propionate—NR3C2—liver—atherosclerosis	0.000265	0.0302	CbGeAlD
Fluticasone Propionate—NR3C1—connective tissue—atherosclerosis	0.000264	0.0301	CbGeAlD
Fluticasone Propionate—NR3C1—cardiovascular system—atherosclerosis	0.00023	0.0262	CbGeAlD
Fluticasone Propionate—Triamcinolone—PTGS2—atherosclerosis	0.000223	0.0711	CrCbGaD
Fluticasone Propionate—CYP3A5—adipose tissue—atherosclerosis	0.000204	0.0233	CbGeAlD
Fluticasone Propionate—NR3C1—adipose tissue—atherosclerosis	0.000202	0.0231	CbGeAlD
Fluticasone Propionate—Betamethasone—PTGS2—atherosclerosis	0.000183	0.0582	CrCbGaD
Fluticasone Propionate—CYP3A5—liver—atherosclerosis	0.000143	0.0163	CbGeAlD
Fluticasone Propionate—NR3C1—liver—atherosclerosis	0.000142	0.0162	CbGeAlD
Fluticasone Propionate—CYP3A4—liver—atherosclerosis	0.000107	0.0122	CbGeAlD
Fluticasone Propionate—Dexamethasone—PTGS2—atherosclerosis	0.000106	0.0339	CrCbGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—APOC3—atherosclerosis	3.47e-05	0.000266	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—LDLR—atherosclerosis	3.45e-05	0.000265	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PLA2G1B—atherosclerosis	3.38e-05	0.000259	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CCL3—atherosclerosis	3.37e-05	0.000259	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	3.29e-05	0.000252	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—FABP4—atherosclerosis	3.29e-05	0.000252	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—LCAT—atherosclerosis	3.29e-05	0.000252	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—ALOX5—atherosclerosis	3.27e-05	0.000251	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—ABCA1—atherosclerosis	3.25e-05	0.000249	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—PARP1—atherosclerosis	3.23e-05	0.000248	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NCF1—atherosclerosis	3.23e-05	0.000248	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—APOA4—atherosclerosis	3.23e-05	0.000247	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—ESR1—atherosclerosis	3.21e-05	0.000246	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—KNG1—atherosclerosis	3.19e-05	0.000245	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—AGTR1—atherosclerosis	3.17e-05	0.000243	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—SERPINE1—atherosclerosis	3.17e-05	0.000243	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CYP7A1—atherosclerosis	3.17e-05	0.000243	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PLG—atherosclerosis	3.09e-05	0.000237	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—AGT—atherosclerosis	3.09e-05	0.000237	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—ESR2—atherosclerosis	3.06e-05	0.000235	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CCR2—atherosclerosis	3.05e-05	0.000234	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—EDNRA—atherosclerosis	3.05e-05	0.000234	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CYBA—atherosclerosis	3.03e-05	0.000233	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PARP1—atherosclerosis	2.97e-05	0.000228	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—GHRL—atherosclerosis	2.97e-05	0.000228	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PLAT—atherosclerosis	2.97e-05	0.000228	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—PPARG—atherosclerosis	2.93e-05	0.000225	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—NAMPT—atherosclerosis	2.93e-05	0.000225	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CYP27A1—atherosclerosis	2.93e-05	0.000225	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—SOCS3—atherosclerosis	2.93e-05	0.000225	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—LIPC—atherosclerosis	2.91e-05	0.000223	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—APOC3—atherosclerosis	2.89e-05	0.000222	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—LDLR—atherosclerosis	2.88e-05	0.000221	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—F2—atherosclerosis	2.85e-05	0.000219	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—VEGFA—atherosclerosis	2.85e-05	0.000218	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MMP3—atherosclerosis	2.83e-05	0.000217	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—MAPK3—atherosclerosis	2.82e-05	0.000216	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—IGF2—atherosclerosis	2.82e-05	0.000216	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CETP—atherosclerosis	2.81e-05	0.000215	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—HMOX1—atherosclerosis	2.79e-05	0.000214	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PLA2G2A—atherosclerosis	2.78e-05	0.000213	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—APOA2—atherosclerosis	2.78e-05	0.000213	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ALOX15—atherosclerosis	2.78e-05	0.000213	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ALOX5AP—atherosclerosis	2.78e-05	0.000213	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ABCG5—atherosclerosis	2.74e-05	0.00021	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—APOB—atherosclerosis	2.73e-05	0.00021	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—PIK3CG—atherosclerosis	2.73e-05	0.000209	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—MAPK3—atherosclerosis	2.69e-05	0.000206	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—SCARB1—atherosclerosis	2.69e-05	0.000206	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—EDN1—atherosclerosis	2.69e-05	0.000206	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—APOB—atherosclerosis	2.67e-05	0.000205	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CCL5—atherosclerosis	2.67e-05	0.000205	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—LPA—atherosclerosis	2.65e-05	0.000203	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—SERPINE1—atherosclerosis	2.64e-05	0.000202	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—TGFB1—atherosclerosis	2.61e-05	0.0002	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—LPL—atherosclerosis	2.61e-05	0.0002	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—KNG1—atherosclerosis	2.61e-05	0.0002	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—GSTM1—atherosclerosis	2.6e-05	0.000199	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—AGTR1—atherosclerosis	2.59e-05	0.000199	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—BGN—atherosclerosis	2.57e-05	0.000197	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—LPL—atherosclerosis	2.55e-05	0.000196	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—CCL2—atherosclerosis	2.54e-05	0.000195	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—HMGCR—atherosclerosis	2.54e-05	0.000195	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—APOA5—atherosclerosis	2.54e-05	0.000195	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PRKCG—atherosclerosis	2.54e-05	0.000195	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PLG—atherosclerosis	2.53e-05	0.000194	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	2.52e-05	0.000193	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—GPX1—atherosclerosis	2.49e-05	0.000191	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—SPP1—atherosclerosis	2.47e-05	0.00019	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—SIRT1—atherosclerosis	2.47e-05	0.000189	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PLA2G1B—atherosclerosis	2.44e-05	0.000188	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—CD36—atherosclerosis	2.42e-05	0.000186	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—SOCS3—atherosclerosis	2.39e-05	0.000183	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PLTP—atherosclerosis	2.37e-05	0.000182	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ALOX5—atherosclerosis	2.36e-05	0.000181	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MMP3—atherosclerosis	2.31e-05	0.000177	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IGF2—atherosclerosis	2.3e-05	0.000176	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—MTHFR—atherosclerosis	2.3e-05	0.000176	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PDGFB—atherosclerosis	2.29e-05	0.000175	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—ABCA1—atherosclerosis	2.26e-05	0.000174	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PPARA—atherosclerosis	2.25e-05	0.000173	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—APOB—atherosclerosis	2.23e-05	0.000171	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—AGT—atherosclerosis	2.23e-05	0.000171	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—EDN1—atherosclerosis	2.2e-05	0.000169	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—APOE—atherosclerosis	2.19e-05	0.000168	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—LEP—atherosclerosis	2.19e-05	0.000168	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—AGT—atherosclerosis	2.18e-05	0.000167	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CCL5—atherosclerosis	2.18e-05	0.000167	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CAV1—atherosclerosis	2.17e-05	0.000166	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—APOA1—atherosclerosis	2.16e-05	0.000166	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—APOE—atherosclerosis	2.14e-05	0.000164	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—LPL—atherosclerosis	2.13e-05	0.000164	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—NAMPT—atherosclerosis	2.12e-05	0.000162	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—CAV1—atherosclerosis	2.12e-05	0.000162	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—APOA1—atherosclerosis	2.11e-05	0.000162	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—LIPC—atherosclerosis	2.1e-05	0.000161	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—APOC3—atherosclerosis	2.09e-05	0.00016	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—ESR1—atherosclerosis	2.09e-05	0.00016	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—LDLR—atherosclerosis	2.08e-05	0.000159	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PRKCG—atherosclerosis	2.07e-05	0.000159	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—F2—atherosclerosis	2.06e-05	0.000158	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ABCG8—atherosclerosis	2.06e-05	0.000158	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—LTA4H—atherosclerosis	2.06e-05	0.000158	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—PPARA—atherosclerosis	2.05e-05	0.000157	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CETP—atherosclerosis	2.03e-05	0.000156	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—SPP1—atherosclerosis	2.02e-05	0.000155	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—CXCL8—atherosclerosis	2.01e-05	0.000154	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PIK3CG—atherosclerosis	1.97e-05	0.000151	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—SCARB1—atherosclerosis	1.94e-05	0.000149	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—HMOX1—atherosclerosis	1.94e-05	0.000149	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PIK3CG—atherosclerosis	1.93e-05	0.000148	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—AKT1—atherosclerosis	1.9e-05	0.000146	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—INS—atherosclerosis	1.87e-05	0.000143	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PDGFB—atherosclerosis	1.87e-05	0.000143	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PPARG—atherosclerosis	1.86e-05	0.000143	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—APOB—atherosclerosis	1.86e-05	0.000143	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—ESR1—atherosclerosis	1.86e-05	0.000142	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CCL2—atherosclerosis	1.84e-05	0.000141	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—HMGCR—atherosclerosis	1.84e-05	0.000141	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—INS—atherosclerosis	1.83e-05	0.00014	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—AGT—atherosclerosis	1.82e-05	0.00014	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—AKT1—atherosclerosis	1.82e-05	0.000139	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—GSTM1—atherosclerosis	1.81e-05	0.000139	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—IGF1—atherosclerosis	1.81e-05	0.000139	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—LEP—atherosclerosis	1.79e-05	0.000137	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—APOE—atherosclerosis	1.79e-05	0.000137	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—LPL—atherosclerosis	1.78e-05	0.000136	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CAV1—atherosclerosis	1.77e-05	0.000136	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—APOA1—atherosclerosis	1.77e-05	0.000135	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—GPX1—atherosclerosis	1.73e-05	0.000133	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—MAPK3—atherosclerosis	1.72e-05	0.000132	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—SERPINE1—atherosclerosis	1.72e-05	0.000132	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—ESR1—atherosclerosis	1.71e-05	0.000131	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—PPARG—atherosclerosis	1.69e-05	0.00013	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CD36—atherosclerosis	1.69e-05	0.000129	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—F2—atherosclerosis	1.69e-05	0.000129	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—ALB—atherosclerosis	1.67e-05	0.000128	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—NOS3—atherosclerosis	1.64e-05	0.000126	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ABCA1—atherosclerosis	1.64e-05	0.000126	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.63e-05	0.000125	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PIK3CG—atherosclerosis	1.61e-05	0.000124	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—NOS3—atherosclerosis	1.6e-05	0.000123	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—MTHFR—atherosclerosis	1.6e-05	0.000123	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PPARA—atherosclerosis	1.57e-05	0.00012	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—MAPK3—atherosclerosis	1.54e-05	0.000118	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—FABP4—atherosclerosis	1.53e-05	0.000117	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—LCAT—atherosclerosis	1.53e-05	0.000117	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—INS—atherosclerosis	1.53e-05	0.000117	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—SERPINE1—atherosclerosis	1.53e-05	0.000117	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—AGT—atherosclerosis	1.52e-05	0.000117	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CCL2—atherosclerosis	1.5e-05	0.000115	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—APOA4—atherosclerosis	1.5e-05	0.000115	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—APOE—atherosclerosis	1.49e-05	0.000114	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IGF1—atherosclerosis	1.48e-05	0.000113	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CAV1—atherosclerosis	1.48e-05	0.000113	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.47e-05	0.000113	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—APOA1—atherosclerosis	1.47e-05	0.000113	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PTGS2—atherosclerosis	1.46e-05	0.000112	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CXCL8—atherosclerosis	1.45e-05	0.000111	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—HMOX1—atherosclerosis	1.4e-05	0.000108	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—SERPINE1—atherosclerosis	1.4e-05	0.000108	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.36e-05	0.000104	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—APOB—atherosclerosis	1.35e-05	0.000103	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PIK3CG—atherosclerosis	1.34e-05	0.000103	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NOS3—atherosclerosis	1.34e-05	0.000103	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MMP9—atherosclerosis	1.31e-05	0.000101	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GSTM1—atherosclerosis	1.31e-05	0.0001	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—NFKB1—atherosclerosis	1.3e-05	9.98e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PPARG—atherosclerosis	1.3e-05	9.95e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.29e-05	9.9e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—APOA2—atherosclerosis	1.29e-05	9.9e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.29e-05	9.9e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.29e-05	9.9e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—LPL—atherosclerosis	1.28e-05	9.85e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MAPK8—atherosclerosis	1.28e-05	9.81e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.28e-05	9.78e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—INS—atherosclerosis	1.27e-05	9.76e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GPX1—atherosclerosis	1.25e-05	9.61e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—LPA—atherosclerosis	1.23e-05	9.45e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CD36—atherosclerosis	1.22e-05	9.36e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—BGN—atherosclerosis	1.19e-05	9.15e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CXCL8—atherosclerosis	1.19e-05	9.11e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—APOA5—atherosclerosis	1.18e-05	9.06e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—VEGFA—atherosclerosis	1.18e-05	9.06e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—STAT3—atherosclerosis	1.17e-05	8.97e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—ALB—atherosclerosis	1.17e-05	8.95e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—AKT1—atherosclerosis	1.16e-05	8.89e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—MTHFR—atherosclerosis	1.16e-05	8.87e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	1.14e-05	8.72e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PPARA—atherosclerosis	1.13e-05	8.7e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—IL6—atherosclerosis	1.13e-05	8.66e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MAPK3—atherosclerosis	1.12e-05	8.57e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—NOS3—atherosclerosis	1.12e-05	8.56e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—AGT—atherosclerosis	1.1e-05	8.43e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ALOX5—atherosclerosis	1.1e-05	8.42e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TGFB1—atherosclerosis	1.08e-05	8.31e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—APOE—atherosclerosis	1.08e-05	8.26e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MMP9—atherosclerosis	1.07e-05	8.24e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CAV1—atherosclerosis	1.07e-05	8.18e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—APOA1—atherosclerosis	1.06e-05	8.16e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NFKB1—atherosclerosis	1.06e-05	8.15e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MAPK8—atherosclerosis	1.04e-05	8.01e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—AKT1—atherosclerosis	1.04e-05	7.99e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PTGS2—atherosclerosis	1.02e-05	7.83e-05	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—MAPK3—atherosclerosis	9.93e-06	7.62e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—NAMPT—atherosclerosis	9.85e-06	7.55e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—LIPC—atherosclerosis	9.78e-06	7.5e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—APOC3—atherosclerosis	9.72e-06	7.46e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PIK3CG—atherosclerosis	9.72e-06	7.45e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—LDLR—atherosclerosis	9.67e-06	7.41e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—VEGFA—atherosclerosis	9.65e-06	7.4e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—STAT3—atherosclerosis	9.55e-06	7.32e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CETP—atherosclerosis	9.44e-06	7.24e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PPARG—atherosclerosis	9.38e-06	7.19e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—INS—atherosclerosis	9.2e-06	7.05e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MAPK3—atherosclerosis	9.12e-06	7e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—SCARB1—atherosclerosis	9.04e-06	6.93e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TGFB1—atherosclerosis	8.85e-06	6.79e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—HMGCR—atherosclerosis	8.54e-06	6.55e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ALB—atherosclerosis	8.43e-06	6.47e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—IL6—atherosclerosis	8.17e-06	6.26e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—NOS3—atherosclerosis	8.07e-06	6.19e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ABCA1—atherosclerosis	7.61e-06	5.84e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—AKT1—atherosclerosis	7.53e-06	5.78e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PTGS2—atherosclerosis	7.38e-06	5.66e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—AKT1—atherosclerosis	7.36e-06	5.64e-05	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—AKT1—atherosclerosis	6.7e-06	5.14e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IL6—atherosclerosis	6.67e-06	5.12e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—HMOX1—atherosclerosis	6.53e-06	5.01e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—APOB—atherosclerosis	6.25e-06	4.8e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—AKT1—atherosclerosis	6.15e-06	4.72e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GSTM1—atherosclerosis	6.08e-06	4.67e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—LPL—atherosclerosis	5.97e-06	4.58e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GPX1—atherosclerosis	5.83e-06	4.47e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CD36—atherosclerosis	5.67e-06	4.35e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—MTHFR—atherosclerosis	5.38e-06	4.12e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PPARA—atherosclerosis	5.27e-06	4.05e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—AKT1—atherosclerosis	5.13e-06	3.93e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—AGT—atherosclerosis	5.11e-06	3.92e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—APOE—atherosclerosis	5.01e-06	3.84e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CAV1—atherosclerosis	4.96e-06	3.8e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—APOA1—atherosclerosis	4.95e-06	3.79e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PIK3CG—atherosclerosis	4.52e-06	3.46e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PPARG—atherosclerosis	4.36e-06	3.34e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—INS—atherosclerosis	4.28e-06	3.28e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ALB—atherosclerosis	3.92e-06	3.01e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—NOS3—atherosclerosis	3.75e-06	2.88e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—AKT1—atherosclerosis	3.71e-06	2.84e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PTGS2—atherosclerosis	3.43e-06	2.63e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—AKT1—atherosclerosis	1.72e-06	1.32e-05	CbGpPWpGaD
